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Abstract
Background: Pandemic influenza A (H1N1) virus emerged during 2009. To help clinicians triage adults with acute respiratory
illness, a scoring system for influenza-like illness (ILI) was implemented at Hospital Civil de Guadalajara, Mexico.
Methods: A medical history, laboratory and radiology results were collected on emergency room (ER) patients with acute
respiratory illness to calculate an ILI-score. Patients were evaluated for admission by their ILI-score and clinicians’ assessment
of risk for developing complications. Nasal and throat swabs were collected from intermediate and high-risk patients for
influenza testing by RT-PCR. The disposition and ILI-score of those oseltamivir-treated versus untreated, clinical
characteristics of 2009 pandemic influenza A (H1N1) patients versus test-negative patients were compared by Pearson’s
X
2, Fisher’s Exact, and Wilcoxon rank-sum tests.
Results: Of 1840 ER patients, 230 were initially hospitalized (mean ILI-score=15), and the rest were discharged, including
286 ambulatory patients given oseltamivir (median ILI-score=11), and 1324 untreated (median ILI-score=5). Fourteen (1%)
untreated patients returned, and 3 were hospitalized on oseltamivir (median ILI-score =19). Of 371 patients tested by RT-
PCR, 104 (28%) had pandemic influenza and 42 (11%) had seasonal influenza A detected. Twenty (91%) of 22 imaged
hospitalized pandemic influenza patients had bilateral infiltrates compared to 23 (38%) of 61 imaged hospital test-negative
patients (p,0.001). One patient with confirmed pandemic influenza presented 6 days after symptom onset, required
mechanical ventilation, and died.
Conclusions: The triaging system that used an ILI-score complimented clinicians’ judgment of who needed oseltamivir and
inpatient care and helped hospital staff manage a surge in demand for services.
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Introduction
The severity of seasonal influenza epidemics is unpredictable
and influenced by the predominant circulating virus strains and
level of immunity in the population [1]. During peak community
influenza activity, hospitals and emergency rooms may be
overwhelmed by patients presenting with influenza-like illness
(ILI) and more severe disease [2,3]. Illness attack rates may be
higher among most age groups during pandemics than observed
for seasonal influenza due to limited immunity among exposed
populations [4]. The re-emergence of highly pathogenic avian
influenza A (H5N1) virus among poultry with sporadic transmis-
sion to exposed persons and the resulting high mortality has
stimulated global influenza pandemic preparedness [5].
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10658Key features of pandemic influenza planning are developing
strategies to meet expected increased demand for patient care,
and how to allocate limited resources, including ventilators and
critical care [6–9]. Guidance has been developed for clinical
triage of patients with ILI, including special populations
(e.g. children, pregnant women), during a pandemic [10–12]. A
key clinical decision is determining which ill persons can be
managed as outpatients and which require hospitalization.
Scoring systems, with varying predictive power, have been
developed to determine who will require hospitalization, need
ICU care, require a ventilator, or is at high risk of death
(e.g. CURB-65)[13–15].
Figure 1. Influenza Scoring System at the Hospital Civil de Guadalajara during the (H1N1) pandemic 2009—Mexico{.
doi:10.1371/journal.pone.0010658.g001
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presented a great challenge for clinicians throughout the world
[16]. Overwhelming demand for medical care by patients with ILI
and limited availability of oseltamivir necessitated that clinicians
rapidly triage patients for outpatient care or hospital admission.
These challenges are compounded by the need for early
oseltamivir treatment of influenza patients for optimal efficacy
[17]. At the Hospital Civil de Guadalajara, Fray Antonio Alcalde
(HCGFAA), Mexico, clinicians from the Adult Infectious Diseases
Unit used a modified ILI scoring system to systematically triage
adult patients with respiratory complaints and determine who
would be prioritized for hospitalization and antivirals. We describe
this triaging system during the peak 2009 pandemic in
Guadalajara (April–August, 2009).
Methods
HCGFAA is a 1000-bed tertiary care facility with a 30-bed
infectious diseases unit. In response to high demand for emergency
medical services among adult patients with acute respiratory
complaints, infectious disease specialists implemented an ILI
scoring system on April 25, 2009. This scoring system was adapted
from a system developed by Hak et al in the United States for
hospitalization decision-making among elderly patients with
pneumonia or influenza during influenza epidemics [18]. In the
emergency room (ER), a questionnaire was used to record
patients’ demographics, signs and symptoms, history of health
care utilization, chronic medical conditions, laboratory, and
radiology findings to calculate patients’ ILI-scores (Figure 1).
Clinicians used an ILI-score $16 (high-risk), their judgment of
patients’ severity of illness and proximity to the hospital to decided
whether to admit the patient and treat them with oseltamivir.
Patients with intermediate ILI-scores (7–15) were discharged from
the ER, treated with oseltamivir and followed daily by phone for
10 days. Those with low ILI-scores (#6) were discharged without
antiviral treatment, and instructed to return if their symptoms
worsened.
Nasal and throat swab specimens were collected from all high-
risk and intermediate-risk patients. Swabs were combined in
phosphate-buffered saline viral transport media and split into
aliquots for influenza testing. One aliquot was tested by rapid
diagnostic test (QuickVue Influenza Test, Quidel, San Diego, CA)
and immunofluorescence at the hospital. A second aliquot was sent
frozen at 270uC to the National Public Health (InDRE)
laboratory in Mexico City. InDRE tested the samples with real-
time RT-PCR (rRT-PCR) using a multiplex assay and 4 sets of
Figure 2. Histogram of patients seeking care for acute respiratory infections at Hospital Civil de Guadalajara during the (H1N1)
pandemic 2009—Mexico.
doi:10.1371/journal.pone.0010658.g002
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influenza A (H1N1), and a control for human genetic material)
[19]. Each hospitalized patient had a chest x-ray and a chest CT
scan performed at admission.
Clinicians prescribed standard doses of oseltamivir 75 mg BID
for five days [17]. Hospitalized patients assessed to have severe
illness received 150 mg of oseltamivir PO BID 65 days, aman-
tadine 300 mg PO BID610 days, broad spectrum antibiotics (e.g.
linezolid), and paracetamol. Patients were discharged when
afebrile and without dyspnea.
Patients’ demographics, clinical presentation, treatments, and
outcome data were entered into an SPSS database. The ILI-score,
treatment, disposition, and virology results of triaged patients were
compared by Pearson’s X
2, Fisher’s Exact, Student t-tests, and
Wilcoxon rank-sum tests.
The study was approved by the research ethics committee of the
Hospital Civil de Guadalajara, Fray Antonio Alcalde and the final
draft for publication was also approved by the research ethics
committee of the Hospital Civil de Guadalajara, Fray Antonio
Alcalde. Investigators kept the datasets in password protected
systems and presented data without identifiers to protect the
anonymity of case-patients.
Results
Disposition of Triaged Patients
During April 25–August 9, hospital staff triaged 1840 persons
with acute respiratory infections (Figure 2). Patients’ median age
was 29 years [IQR 22–41 years] and 55% were female. Of the
1840 ER patients, 167 (9.1%) were classified at high risk (mean
ILI-score=19), 725 (39.4%) at intermediate risk (median ILI-
score=10), and 945 (51.4%) at low risk (median ILI-score=3) of
developing complications of presumptive 2009 pandemic influenza
A (H1N1) disease (Table 1). Two-hundred and thirty (12.5%) were
admitted to hospital (median ILI-score=15 [IQR=11–19])
(Figure 3). Of 286 ambulatory patients who were prescribed
oseltamivir (median ILI-score=11, IQR=7–15), none required
subsequent medical evaluation. Of 1324 ambulatory patients who
were not treated with oseltamivir (median ILI-score=5, IQR=1–
8), 14 (0.8%) returned a median of 8 days after their initial visit.
Three (21%) of the 14 returning patients (i.e. one pregnant and
two with a history of tobacco abuse), were hospitalized and treated
with oseltamivir (with a median ILI-score =19). Two of these 3
returning patients who were subsequently hospitalized tested
positive for 2009 pandemic influenza (H1N1). One (7%) of the 14
returning patients was prescribed oseltamivir and discharged from
the ED, and 10 (71%) were discharged home without oseltamivir.
One patient visited triage three times, but was not treated with
oseltamivir. Three deaths occurred in hospitalized patients (aged
18, 37, and 54 years). Decedents presented to the ER a mean of 4
days after symptom onset with a mean ILI score of 16. One
decedent was confirmed with pandemic H1N1, one had seasonal
influenza A, and one was not tested. All other hospitalized patients
improved and were discharged home.
Characteristics of hospitalized patients
Hospitalized patients presented within a median of 2 days after
symptom onset with dyspnea and abnormal findings on chest
imaging. Sixty-seven (30%) of the 230 hospitalized patients
smoked tobacco (for a mean duration of 8 years), 45 (20%) had a
Table 1. Demographic Characteristics of Patients Seeking Care for acute respiratory infection at the Hospital Civil de Guadalajara
during the (H1N1) pandemic 2009—Mexico.
Demographics N (%)
All initially
triaged
patients
(N=1840)
All hospitalized
patients treated
with oseltamivir
(N=233){
All ambulatory
patients treated
with oseltamivir
as outpatients
(N=286) {
Patients
discharged from
triage without
oseltamivir
(N=1324)
All patients
treated with
oseltamivir with
seasonal influenza
A cases (N=42)‘
All patients
treated with
oseltamivir with
pandemic (H1N1)
2009 cases
(N=104) ‘
Median age 29 28 29 29 31 23*
Females 1017 (55%) 134 (58%) 154 (54%) 741 (55%) 20 (48%) 45 (43%)
Most Frequently Reported
Occupations
Home makers 376 (20%) 62 (27%) 32 (11%) 287 (22%) 8 (19%) 12 (12%)
Students 288 (16%) 40 (17%) 51 (18%) 198 (15%) 3 (7%) 28 (28%)
Health care workers 230 (13%) 17 (7%) 88 (31%) 126 (10%) 6 (14%) 13 (12%)
Retail workers 163 (9%) 18 (8%) 14 (5%) 132 (10%) 4 (10%) 3 (3%)
Construction workers 121 (7%) 8 (3%) 4 (1%) 111 (8%) 2 (5%) 5 (4%)
Unemployed 74 (4%) 11 (5%) 4 (1%) 60 (5%) 3 (7%) 1 (1%)
Assessment of risk
High risk 167 (9%) 114 (49%) 52 (18%) 4 (0.3%) 14 (33%) 38 (37%)
Intermediate risk 725 (39%) 104 (45%) 173 (60%) 451 (34%) 18 (43%) 49 (47%)
Low risk 945 (51%) 15 (6%) 59 (21%) 880 (66%) 10 (24%) 14 (16%)¥
Median ILI-score 6 15 11 5 14 13
*Difference between seasonal influenza and pandemic (H1N1), 2009, p=0.0007.
¥2% of pandemic (H1N1) 2009 missing risk assessment information.
{Includes all hospitalized cases regardless of influenza RT-PCR test results.
‘Includes all hospitalized cases and ambulatory patients treated with oseltamivir who tested positive for influenza A.
doi:10.1371/journal.pone.0010658.t001
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(10%) had a history of other drug use (Table 2). Ninety-one
percent of hospitalized patients reported fatigue, 90% headache,
88% myalgias, 86% fever, 82% chills, and 63% dry cough
(Table 3). During triage, fever (i.e. measured temperature
$38uC) was documented in 184 (79%) of the 233 hospitalized
patients (Table 4). Sixteen (33%) of the 49 hospitalized patients
who were afebrile at triage reported using paracetamol, non-
steroidal anti-inflammatory medications or oral corticosteroids
prior to their ER visit. Nine (4%) of the 233 hospitalized patients
had hypoxia (i.e. PO2 ,70), 4 had hypotension (blood pressure
,90/60), and 3 required invasive mechanical ventilation. One-
hundred and fifty-six (69%) of 233 hospitalized patients had
lymphopenia compared to 117 (41%) of 286 ambulatory patients
treated with oseltamivir (p,0.0001). Similarly, 35 (15%) of 233
hospitalized patients had thrombocytopenia compared to 19 (7%)
of 286 ambulatory patients treated with oseltamivir (p,0.001).
Out of the 181 hospitalized patients tested, 36 (20%) were
positive for 2009 pandemic influenza A (H1N1) and 24 (13%)
were positive for seasonal influenza A. Similarly, out of the 187
hospitalized patients tested, 68 (36%) were positive for 2009
pandemic influenza A (H1N1) and 18 (10%) were positive for
seasonal influenza A.
Clinical presentation of patients who tested positive for
2009 pandemic influenza A (H1N1) virus
Of the 1840 persons triaged, 379 (21%) were tested for influenza
(i.e. 371 (20%) by rRT-PCR, 112 (6%) by rapid diagnostic test,
and 89 (5%) by immunofluorescence). Of the 371 patients tested
by rRT-PCR, 104 (28%) had pandemic (H1N1) and 42 (11%) had
seasonal influenza A detected. There was a 0.51 correlation
between rRT-PCR and rapid diagnostic test results among the 85
patients who were tested by both methods (p,0.001). In contrast,
there was a 0.15 correlation between rRT-PCR and immunoflu-
orescence results among the 57 who were tested by both methods.
In comparison to patients with seasonal influenza, patients whose
rRT-PCR tested positive for 2009 pandemic influenza A (H1N1)
were younger (Figure 4). The median age of patients who tested
positive for 2009 pandemic influenza A (H1N1) was 23 years
versus 31 years for patients who tested positive for seasonal
Figure 3. Patients seeking care with acute respiratory infections at the Hospital Civil de Guadalajara during the (H1N1) pandemic
2009—Mexico.
doi:10.1371/journal.pone.0010658.g003
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positive for 2009 pandemic influenza A (H1N1) were not more
likely to be pregnant, report substance abuse, have other medical
conditions (e.g. obesity), or require hospitalization within 2 days of
developing symptoms than other patients (Table 2). At ER
presentation, 69 (66%) of the 104 patients whose rRT-PCR tested
positive for 2009 pandemic influenza A (H1N1) reported a dry
cough (mean duration =3 days) versus 145 (55%) of 264 test
negative patients (p=0.03). Thirty-two (31%) the 104 patients
whose rRT-PCR tested positive for 2009 pandemic influenza A
(H1N1) had a productive cough compared to 53 (20%) of 262 test
negative patients (p=0.03). Patients whose rRT-PCR tested
positive for 2009 pandemic influenza A (H1N1) presented with a
median temperature of 38.5uC which, on average, started 2 days
before admission [IQR1–3]. There were no differences in WBC at
ER presentation between patients whose rRT-PCR tested positive
for 2009 pandemic influenza A (H1N1) and patients who tested
negative for 2009 pandemic influenza A (H1N1).
Radiological findings of hospitalized patients
Eighteen (60%) of 30 hospitalized patients infected with 2009
pandemic influenza A (H1N1) with chest X-rays had abnormal
findings while all 22 with chest CT scans had abnormal findings
(Table 4). Similarly, 5 (25%) of 20 hospitalized patients infected
with seasonal influenza A who had chest X-rays had abnormal
findings while all 10 who had chest CT had abnormal findings.
Hospitalized patients infected with 2009 pandemic influenza A
(H1N1) were more likely to have abnormal chest X-rays than
patients infected with seasonal influenza A (p=0.02) (Table 4).
Twenty (91%) of 22 imaged hospitalized patients infected with
2009 pandemic influenza A (H1N1) had bilateral infiltrates on
chest X-ray or CT compared to 23 (38%) of 61 imaged patients
who tested negative for 2009 pandemic influenza A
(H1N1)(p,0.001). Similarly, more patients infected with 2009
pandemic influenza A (H1N1) had chest X-rays and CT scans
with thickened interlobar septa (p,0.001), involvement of the
middle zone (p,0.001), compared to imaged patients who tested
negative for 2009 pandemic influenza A (H1N1) (Table 4)
(Figure 5).
Risk factors for increased length of hospitalization among
2009 pandemic influenza A (H1N1) cases
Testing positive for 2009 pandemic influenza A (H1N1) was not
associated with prolonged stay. On average, 2009 pandemic
influenza A (H1N1) patients were hospitalized for a median of 2
days [IQR 1–3days]. 2009 Pandemic influenza A (H1N1) infected
patients with dyspnea on admission had a mean hospital stay of 2.1
days while those without dyspnea had a mean hospital stay of 1.3
days. The one decedent infected with pandemic influenza A
(H1N1) presented 6 days after symptom onset with dyspnea and a
10 year history smoking history. There were no reported adverse
events among patients associated with the use of oseltamivir.
Discussion
During 6 weeks when there was co-circulation of pandemic and
seasonal influenza A viruses in the community, hospital staff
triaged more than eighteen-hundred patients with respiratory
Table 2. Symptoms of Patients Seeking Care for Acute Respiratory Infections at the Hospital Civil de Guadalajara during the
(H1N1) pandemic 2009—Mexicoe.
All initially triaged
patients (N=1239)
All hospitalized
patients treated with
oseltamivir (N=233){
All ambulatory patients
treated with oseltamivir
as outpatients (N=286) {
All patients treated
with oseltamivir with
seasonal influenza
A cases (N=42) ‘
All patients treated
with oseltamivir with
pandemic (H1N1) 2009
cases (N=104) ‘
Past medical history N( % )
Smoking 67 (30%) 4 (1%) 8 (19%) 13 (12%)
Alcoholism 45 (20%) 6 (2%) 6 (14%) 10 (10%)
Drug abuse 22 (10%) 0 (0%) 4 (10%) 3 (3%)
Hypertension 20 (9%) 5 (2%) 3 (7%) 4 (4%)
Diabetes 13 (6%) 7 (2%) 4 (10%) 2 (2%)
Tuberculosis 11 (5%) 1 (0.3%) 2 (5%) 1 (1%)
Asthma 9 (4%) 5 (2%) 1 (2%) 1 (1%)
Other lung disease 9 (4%) 3 (1%) 2 (5%) 1 (1%)
Other immune suppression 8 (4%) 5 (2%) 1 (2%) 2 (2%)
Neurological disease 5 (2%) 1 (0.3%) 1 (2%) 1 (1%)
Chronic renal problems 5 (2%) 2 (1%) 2 (5%) 2 (2%)
HIV 4 (2%) 1 (0.3%) 0 (0%) 0 (0%)
Pregnancy 3 (2%) 1 (0.3%) 0 (0%) 0 (0%)
Obesity 3 (1%) 0 (0%) 0 (0%) 1 (1%)
Malnutrition 2 (1%) 0 (0%) 0 (0%) 1 (1%)
Transplant 2 (1%) 1 (0.3%) 0 (0%) 1 (1%)
Influenza vaccine 31 (13%) 52 (18%) 8 (19%) 13 (12%)
{Includes all hospitalized cases regardless of influenza RT-PCR test results.
‘Includes all hospitalized cases and ambulatory patients treated with oseltamivir who tested positive for influenza A.
eInsufficient data available from patients discharged from triage without oseltamivir to include in table.
doi:10.1371/journal.pone.0010658.t002
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system was based on assumptions about who is at risk for
developing complications from seasonal influenza (e.g. patients
aged over 65 years). Our analyses, however, suggested that
patients infected with 2009 pandemic influenza A (H1N1) tended
to be younger than seasonal influenza A patients. Nevertheless,
our data suggest that clinicians used the ILI-score to help them
determine, with minimal misclassification, which patients needed
hospitalization versus who could be managed as outpatients [18].
The ILI-score helped guide clinicians to decide who needed
hospital care and antiviral treatment when timely laboratory
confirmation of influenza was not available. Only 1% of patients
triaged needed re-evaluation. Such a system could be readily used
to efficiently triage patients during outbreaks and epidemics by
adapting the system’s scores to match the anticipated character-
istics of patients who are at highest risk of developing
complications.
While the triaging system led clinicians to hospitalize
traditional groups at risk for complications from seasonal
influenza (i.e. those with chronic medical illnesses), patients
infected with 2009 pandemic influenza A (H1N1) were often
young and had few pre-existing conditions [20]. These data are
comparable with Mexican Directorate General of Epidemiology
data that suggest 56% of pandemic (H1N1) confirmed deaths
occurred among those aged 30–59 years, many of whom were
previously healthy [21]. The age shift in 2009 pandemic influenza
A (H1N1) cases may be caused by cross-reactive immunity from
prior influenza infections in 33% of those aged more than 60
years [22,23]. Health officials should adjust pandemic triaging
tools to account for the younger age distribution of cases [24].
Pregnancy should also be included as a risk factor in triaging
tools. Although there were too few pregnant women in our case
series for subgroup analyses, other data suggest pregnant women
are at high risk of developing severe complications from 2009
pandemic influenza A (H1N1) [25].
In this case series, hospitalized patients who tested positive for
2009 pandemic influenza A (H1N1) received oseltamivir within 2
days of symptom onset and appeared to recover quickly with a
median hospital stay of two days. Similarly, no ambulatory
patients treated with oseltamivir required further medical care. In
contrast, 3 patients initially discharged from the ED without
oseltamivir returned to triage and required hospital admission.
Two of these 3 later tested positive for 2009 pandemic influenza A
(H1N1). One additional patient who required mechanical
ventilation and subsequently died had presented 6 days after
symptom onset. Another 5 hospital decedent whose care was
transferred to the infectious disease service and therefore not part
of our triaged case-series presented a median of 15 days after
symptom onset. These cases suggest the importance of early
oseltamivir treatment.
Table 3. Presenting Symptoms of Patients Seeking Care for Acute Respiratory Infections at the Hospital Civil de Guadalajara
during the (H1N1) pandemic 2009—Mexico.
All initially
triaged
patients
(N=1840)
All hospitalized
patients treated
with oseltamivir
(N=233){
All ambulatory
patients treated
with oseltamivir as
outpatients
(N=286) {
Patients
discharged
from triage
without oseltamivir
(N=1324)
All patients
treated with
oseltamivir
with seasonal
influenza A cases
(N=42) ‘
All patients
treated with
oseltamivir with
pandemic (H1N1)
2009 cases
(N=104) ‘
Symptoms N( % )
Median symptom
onset before
presentation
2d 2d 2d 2d 2d 2d
Headache 1460 (79%) 210 (90%) 249 (87%) 10111 (76%) 32 (76%) 93 (88%)*
Myalgia 1336 (73%) 204 (88%) 224 (78%) 919 (69%) 31 (74%) 85 (81%)
Fatigue 1254 (68%) 212 (91%) 228 (79%) 829 (62%) 33 (79%) 88 (83%)
Sore throat 1251 (68%) 163 (70%) 192 (67%) 906 (68%) 28 (67%) 75 (70%)
Chills 1087 (59%) 190 (82%) 203 (71%) 704 (53%) 32 (76%) 76 (74%)
Dry cough 951 (52%) 147 (63%) 172 (60%) 637 (48%) 23 (55%) 69 (64%)
Subjective Fever 888 (48%) 201 (86%) 203 (71%) 492 (37%) 33 (79%) 90 (85%)
Conjunctivitis 791 (43%) 127 (55%) 115 (40%) 556 (42%) 22 (52%) 48 (46%)
Rhinorrhea 637 (35%) 100 (43%) 153 (53%) 387 (29%) 17 (40%) 53 (51%)
Thoracic pain 561 (30%) 130 (56%) 109 (38%) 329 (24%) 24 (57%) 49 (45%)
Productive cough 492 (27%) 47 (20%) 66 (23%) 381 (29%) 8 (19%) 32 (31%)
Dyspnea 438 (24%) 120 (52%) 90 (31%) 230 (17%) 13 (31%) 42 (40%)
Diarrhea 244 (13%) 56 (24%) 57 (20%) 132 (10%) 7 (17%) 21 (20%)
Abdominal pain 240 (13%) 52 (23%) 56 (20%) 132 (10%) 7 (17%) 21 (20%)
Rales 37 (2%) 33 (14%) 4 (1%) 0 (0%) 4 (10%) 3 (3%)
Wheezing 14 (1%) 13 (6%) 1 (0.3%) 0 (0%) 0 (0%) 1 (1%)
*p=0.04 when comparing pandemic (H1N1) 2009 test positives to seasonal influenza A test positives.
{Includes all hospitalized cases regardless of influenza RT-PCR test results.
‘Includes all hospitalized cases and ambulatory patients treated with oseltamivir who tested positive for influenza A.
doi:10.1371/journal.pone.0010658.t003
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pandemic influenza A (H1N1) case-patients died. These findings
contrast those of the National Institute of Respiratory Diseases in
Mexico City where 12 (67%) of 18 patients required mechanical
ventilation and 7 (39%) patients died [24,26]. The discrepancy
between these two case-series may be explained by when the
populations served by these hospitals were affected by the
pandemic. National Institute of Respiratory Diseases data were
collected during March 24–April 24, 2009, when it was still
unclear that a proportion of cases with severe acute respiratory
infections had 2009 pandemic influenza A (H1N1). In Guada-
lajara, the outbreak started later. Hospitalized patients we
described received earlier oseltamivir. Our patients were
hospitalized during April 25–August 9. Seventy-five percent of
our case-patients received oseltamivir within 72 hours of
symptom onset. Patients in the Mexico City case-series presented
with severe disease an average of 8 days after illness onset and
received late oseltamivir.
Our findings have important limitations. A minority of all
patients had respiratory specimens tested by RT-PCR, a large
number of patients who were triaged were not confirmed with
seasonal influenza or 2009 pandemic influenza A (H1N1) virus
infection. No testing for other etiologies of acute respiratory illness
was performed. Oseltamivir treatment among hospitalized patients
was not randomized among cases and control. No comparison
group was available to assess oseltamivir effectiveness for the
treatment of 2009 pandemic influenza A (H1N1).
The triaging system with its ILI-score needs further validation.
Nevertheless, such a triaging system can help guide the clinical
management of patients presenting to the ED with acute
respiratory illness in settings that lack timely diagnostic testing
and have limited antivirals supplies. With some adaptation, the
system may be especially useful in resource-poor countries, during
the peak of pandemic influenza, or during other respiratory virus
activity. Although no scoring system will replace clinical judgment,
our experience suggests that the triaging system may have helped
clinicians effectively triage patients and determine who needed
hospital care and who could be managed as outpatients. The
triaging system and the ILI-score should be modified to the local
2009 pandemic influenza A (H1N1) situation based upon hospital
Table 4. Findings of patients seeking care for acute respiratory infections at the Hospital Civil de Guadalajara during the (H1N1)
pandemic 2009—Mexico e.
All hospitalized patients
treated with oseltamivir
(N=233){
All ambulatory
patients treated
with oseltamivir as
outpatients (N=286) {
All patients treated
with oseltamivir with
seasonal influenza A
cases (N=42) ‘
All patients treated
with oseltamivir with
pandemic (H1N1) 2009
cases (N=104) ‘
Findings
Median temperature (uC) 38.5 37.7 38.5 38
Hypoxia N (%) 9 (5%) 0 (0%) 1 (2%) 1 (1%)
Lymphopenia 156 (69%) 117 (41%) 27 (64%) 66 (63%)
Thrombocytopenia 35 (15%) 19 (7%) 2 (5%) 9 (9%)
Radiology N (%) Of 205 hospitalized patients
who had chest X-ray
[of which 83 had chest CT]
Of 258 ambulatory
patients who had
chest X-ray [of
which 35 had chest CT]
Of 36 patients who tested
positive for seasonal
influenza A and who had
chest X-ray s[of which 16
had chest CT]
Of 95 patients who
tested positive for
pandemic (H1N1) and
who had chest X-rays
[of which 30 had
chest CT]
Abnormal chest X-ray 79 (39%) 112 (43%) 14 (39%) 59 (62%)¥
Abnormal lung CT 91 (97%) 30 (86%) 16 (100%) 30 (100%)
Bilateral infiltrates 49 (53%) 23 (64%) 12 (75%) 28 (93%)*
Tree-in bud appearance 69 (73%) 26 (72%) 15 (94%) 28 (93%)*
Involvement of basal zone 62 (66%) 24 (67%) 16 (100%) 30 (100%)*
Air trapping 52 (55%) 23 (64%) 15 (94%) 27 (90%)*
Centrilobular nodules 49 (52%) 21 (58%) 13 (81%) 24 (80%)*
Thickened interlobar septa 48 (51%) 21 (58%) 12 (75%) 28 (93%)*
Multifocal distribution 38 (40%) 13 (36%) 11 (69%) 19 (63%)*
Involvement of middle zone 27 (29%) 9 (25%) 6 (37%) 18 (60%)*
Segmental consolidation 15 (16%) 1 (3%) 1 (6%) 5 (17%)
Segmental distribution 14 (15%) 0 (0%) 1 (6%) 3 (10%)
Involvement of apical zone 10 (11%) 4 (11%) 1 (6%) 3 (10%)
Peribronchial ground glass 7 (7%) 4 (11%) 1 (6%) 7 (23%)*
¥p=0.01 when comparing patients who tested positive for seasonal influenza A with those who tested positive for pandemic (H1N1) 2009.
*p#0.009 when comparing patients who tested positive for pandemic (H1N1) 2009 to those who tested negative.
{Includes all hospitalized cases regardless of influenza RT-PCR test results.
‘Includes all hospitalized cases and ambulatory patients treated with oseltamivir who tested positive for influenza A.
eInsufficient data available from patients discharged from triage without oseltamivir to include in table.
doi:10.1371/journal.pone.0010658.t004
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